⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27495036 | 0.70 | — | — | |
| SCHEMBL16423308 | 0.68 | ALDH1A1 (0.36) | — | |
| SCHEMBL7659407 | 0.65 | — | — | |
| SCHEMBL2506587 | 0.65 | — | — | |
| SCHEMBL817902 | 0.65 | — | — | |
| SCHEMBL9621128 | 0.63 | ALDH1A1 (0.36) | — | |
| SCHEMBL1930705 | 0.61 | — | — | |
| SCHEMBL815142 | 0.61 | — | — | |
| SCHEMBL816417 | 0.60 | ALDH1A1 (0.31) | — | |
| SCHEMBL817441 | 0.60 | ALDH1A1 (0.31) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 44 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11931445-B2 | Composition comprising baicalin | L'OREAL (FR) | 2024-03-19 | — | — | US | disclosed |
| CN-111343966-B | Composition comprising baicalin and specific acrylic polymer | 莱雅公司 | 2023-10-20 | — | — | CN | disclosed |
| CN-116898752-A | Composition comprising baicalin and specific acrylic polymer | 莱雅公司 | 2023-10-20 | — | — | CN | disclosed |
| WO-2023067251-A1 | COMPOSITION FOR USE IN THE CUTANEOUS SYNTHESIS OF HYALURONIC ACID, IN AN IMMUNO-CUTANEOUS RESPONSE AND TO IMPROVE SKIN | JR (FR) | 2023-04-27 | — | — | WO | disclosed |
| US-11547648-B2 | Composition comprising baicalin and a particular acrylic polymer | L'OREAL (FR) | 2023-01-10 | — | — | US | disclosed |
| EP-3558253-B1 | COMPOSITION COMPRISING BAICALIN | OREAL (FR) | 2022-12-28 | — | — | EP | disclosed |
| CN-110087609-B | Water-in-oil emulsion containing baicalin, xanthine base, vitamin B3, and polyvalent metal cation salt | 莱雅公司 | 2022-11-15 | — | — | CN | disclosed |
| US-11376205-B2 | Water-in-oil emulsion containing baicalin, a xanthine base, a vitamin B3, and a polyvalent metal cation salt | L'OREAL (FR) | 2022-07-05 | — | — | US | disclosed |
| US-20200297612-A1 | COMPOSITION COMPRISING BAICALIN AND A PARTICULAR ACRYLIC POLYMER | L'OREAL (FR) | 2020-09-24 | — | — | US | disclosed |
| EP-3558216-B1 | WATER-IN-OIL EMULSION CONTAINING BAICALIN, A XANTHINE BASE, A VITAMIN B3, AND A POLYVALENT METAL CATION SALT | L'ORÉAL (FR) | 2020-09-16 | — | — | EP | disclosed |
| WO-2012085648-A1 | PHOSPHORUS-SUBSTITUTED QUINOXALINE-TYPE PIPERIDINE COMPOUNDS AND USES THEREOF | PURDUE PHARMA L.P. (US) | 2012-06-28 | — | — | WO | disclosed |
| US-20100137306-A1 | HETEROCYCLIC TRPV1 RECEPTOR LIGANDS | PURDUE PHARMA L.P. | 2010-06-03 | — | — | US | disclosed |
| US-20100130552-A1 | Therapeutic Agents Useful for Treating Pain | PURDUE PHARMA L.P. | 2010-05-27 | — | — | US | disclosed |
| EP-2091936-A1 | THERAPEUTIC AGENTS USEFUL FOR TREATING PAIN | Purdue Pharma LP (US) | 2009-08-26 | — | — | EP | disclosed |
| WO-2008133973-A1 | THERAPEUTIC AGENTS USEFUL FOR TREATING PAIN | PURDUE PHARMA L.P. (DE) | 2008-11-06 | — | — | WO | disclosed |
| WO-2007117289-A2 | METHODS FOR TREATING OR PREVENTING ERECTILE DYSFUNCTION OR URINARY INCONTINENCE | INOTEK PHARMACEUTICALS CORPORATION (US) | 2007-10-18 | — | — | WO | disclosed |
| CN-1902178-A | Therapeutic agents useful for treating pain | EURO CELTIQUE SA (LU) | 2007-01-24 | — | — | CN | disclosed |
| CN-1863790-A | Therapeutic agents useful for treating pain | EURO CELTIQUE SA (LU) | 2006-11-15 | — | — | CN | disclosed |
| CN-1856489-A | Phenyl-carboxamide compounds useful for treating pain | EURO CELTIQUE SA (LU) | 2006-11-01 | — | — | CN | disclosed |
| CN-1832935-A | Therapeutic agent for treating pain | EURO CELTIQUE SA (LU) | 2006-09-13 | — | — | CN | disclosed |